A comparison of AA genotype carriers in the two groups of patients and controls in terms of KIR2DS4 variants revealed that the frequency of the del/del genotype was significantly higher in severely ill COVID-19 patients. This evidence concerns the gene KIR2DS4 and COVID-19.